Elevance Health (ELV) Change in Receivables (2010 - 2026)

Elevance Health (ELV) has 17 years of Change in Receivables data on file, last reported at $1.2 billion in Q1 2026.

• Quarterly Change in Receivables fell 63.01% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $526.0 million (down 85.29% YoY) and the FY2025 annual result came in at $2.5 billion, up 269.84% from the prior year.
• Change in Receivables improved to $1.2 billion in Q1 2026 per ELV's latest filing, from -$756.0 million in the prior quarter.
• Across five years, Change in Receivables topped out at $3.2 billion in Q1 2025 and bottomed at -$851.0 million in Q3 2024.
• The 5-year median for Change in Receivables is $282.0 million (2024), against an average of $509.1 million.
• The widest annual swing landed in 2023, when Change in Receivables jumped 2575.0%; it then slumped 491.71% in 2025.
• Tracing ELV's Change in Receivables over 5 years: stood at $1.8 billion in 2022, then tumbled by 43.5% to $1.0 billion in 2023, then tumbled by 81.35% to $193.0 million in 2024, then tumbled by 491.71% to -$756.0 million in 2025, then soared by 255.29% to $1.2 billion in 2026.
• Per Business Quant, the three latest ELV Change in Receivables figures stand at $1.2 billion (Q1 2026), -$756.0 million (Q4 2025), and -$815.0 million (Q3 2025).

Peer Comparison